AI summary

100% confidence

MES research with healthcare focus on medical. Since the dawn of civilization, it has been understood that pathogenic microorganisms cause infectious conditions in hum...

Generated by MESSAI extraction pipeline · review against source PDF

Extraction

Reported parameters

No values extracted from this paper yet.

No 3D model is mapped to this paper yet. Parameter ranges above still place reported values on the literature distribution.

What they did

System
REVIEW

What worked

No outcome metrics extracted yet.

Abstract

Since the dawn of civilization, it has been understood that pathogenic microorganisms cause infectious conditions in humans, which at times, may prove fatal. Among the different virulent properties of microorganisms is their ability to form biofilms, which has been directly related to the development of chronic infections with increased disease severity. A problem in the elimination of such complex structures (biofilms) is resistance to the drugs that are currently used in clinical practice, and therefore, it becomes imperative to search for new compounds that have anti-biofilm activity. In this context, nanotechnology provides secure platforms for targeted delivery of drugs to treat numerous microbial infections that are caused by biofilms. Among the many applications of such nanotechnology-based drug delivery systems is their ability to enhance the bioactive potential of therapeutic agents. The present study reports the use of important nanoparticles, such as liposomes, microemulsions, cyclodextrins, solid lipid nanoparticles, polymeric nanoparticles, and metallic nanoparticles, in controlling microbial biofilms by targeted drug delivery. Such utilization of these nanosystems has led to a better understanding of their applications and their role in combating biofilms.

Keywords

BiofilmDrug deliveryNanotechnologyContext (archaeology)NanomedicineDrug

Identifiers

Journal
International Journal of Nanomedicine
Year
2018